1. Home
  2. VSEC vs PTCT Comparison

VSEC vs PTCT Comparison

Compare VSEC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VSE Corporation

VSEC

VSE Corporation

SELL

Current Price

$161.55

Market Cap

5.0B

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$60.45

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VSEC
PTCT
Founded
1959
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.5B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
VSEC
PTCT
Price
$161.55
$60.45
Analyst Decision
Strong Buy
Buy
Analyst Count
11
15
Target Price
★ $260.44
$100.33
AVG Volume (30 Days)
436.4K
★ 1.2M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
★ 0.25%
N/A
EPS Growth
N/A
★ 264.48
EPS
★ 1.94
0.90
Revenue
★ $760,113,000.00
$264,734,000.00
Revenue This Year
$63.13
N/A
Revenue Next Year
$21.44
$9.47
P/E Ratio
$83.54
★ $67.73
Revenue Growth
9.88
★ 36.19
52 Week Low
$152.34
$58.80
52 Week High
$247.85
$90.87

Technical Indicators

Market Signals
Indicator
VSEC
PTCT
Relative Strength Index (RSI) 38.22 34.61
Support Level $161.15 N/A
Resistance Level $186.49 $68.93
Average True Range (ATR) 8.35 1.88
MACD 0.57 -0.15
Stochastic Oscillator 39.41 13.26

Price Performance

Historical Comparison
VSEC
PTCT

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: